Patient news

LX2006: Friedreich Ataxia (FA) Cardiomyopathy

March 30, 2026

LX2006 Update in Lexeo Fourth Quarter and Full Year 2025 Earnings

Announcement

October 7, 2025

LX2006 Interim Clinical Data

Announcement

July 10, 2025

LX2006 Breakthrough Therapy Designation

Announcement

April 8, 2025

LX2006 Interim Clinical Data

Announcement

March 24, 2025

LX2006 Development Update

Announcement

LX2020: PKP2 Arrhythmogenic Cardiomyopathy (ACM)

March 30, 2026

LX2020 Update in Lexeo Fourth Quarter and Full Year 2025 Earnings

Announcement

March 24, 2025

LX2020 Interim Clinical Data

Announcement

Contact Us

Investor Inquiries
investors@lexeotx.com
Media Inquiries
media@lexeotx.com